Mindfulness-Based Therapies Effectively Treat Cardiovascular Disease

Mindfulness-Based Therapies Effectively Treat Cardiovascular Disease

 

By John M. de Castro, Ph.D.

 

What’s good for the mind also tends to be good for the heart. The mind-calming practice of meditation may play a role in reducing your risk of heart disease.” – Harvard Health

 

Cardiovascular disease is the number one killer. A myriad of treatments has been developed including a variety of surgical procedures and medications. In addition, lifestyle changes have proved to be effective including quitting smoking, weight reduction, improved diet, physical activity, and reducing stresses. Unfortunately, for a variety of reasons, 60% of cardiovascular disease patients decline engaging in these lifestyle changes, making these patients at high risk for another attack.

 

Contemplative practices have been shown to be safe and effective alternative treatments for cardiovascular disease. Practices such as meditation, tai chi, and yoga, have been shown to be helpful for heart health and to reduce the physiological and psychological responses to stress. They have also been shown to be effective in maintaining cardiovascular health and the treatment of cardiovascular disease. The research has been accumulating. So, it makes sense to pause and take a look at what has been learned.

 

In today’s Research News article “Mindfulness-Based Interventions for Physical and Psychological Wellbeing in Cardiovascular Diseases: A Systematic Review and Meta-Analysis.” (See summary below or view the full text of the study at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227381/ ) Marino and colleagues review, summarize and perform a meta-analysis of the published research studies of the effectiveness of mindfulness-based therapies for the treatment of cardiovascular diseases. They identified 17 published research studies.

 

They report that the published research studies found that mindfulness-based therapies produced significant decreases in systolic blood pressure, heart palpitations, heart rate, depression, and perceived stress, and significant increases in the quality of life of patients with cardiovascular disease. Hence, mindfulness-based therapies are effective in improving the physiological and psychological state of patients with cardiovascular disease and should be recommended for the treatment of these patients.

 

So, mindfulness-based therapies effectively treat cardiovascular disease.

 

people who meditated had lower rates of high cholesterol, high blood pressure, diabetes, stroke, and coronary artery disease.” – Science Daily

 

CMCS – Center for Mindfulness and Contemplative Studies

 

This and other Contemplative Studies posts are also available on Google+ https://plus.google.com/106784388191201299496/posts and on Twitter @MindfulResearch

 

Study Summary

 

Marino, F., Failla, C., Carrozza, C., Ciminata, M., Chilà, P., Minutoli, R., Genovese, S., Puglisi, A., Arnao, A. A., Tartarisco, G., Corpina, F., Gangemi, S., Ruta, L., Cerasa, A., Vagni, D., & Pioggia, G. (2021). Mindfulness-Based Interventions for Physical and Psychological Wellbeing in Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Brain sciences, 11(6), 727. https://doi.org/10.3390/brainsci11060727

 

Abstract

Background: Recently, there has been an increased interest in the efficacy of mindfulness-based interventions (MBI) for people with cardiovascular diseases (CVD), although the exact beneficial effects remain unclear. Methods: This review aims to establish the role of MBI in the management of wellbeing for patients with CVD. Seventeen articles have been included in this systematic synthesis of the literature and eleven in the meta-analysis. Results: Considering physical (i.e., heart rate, blood pressure) and psychological outcomes (i.e., depression, anxiety, stress, styles of coping), the vast majority of studies confirmed that MBI has a positive influence on coping with psychological risk factors, also improving physiological fitness. Random-effects meta-analysis models suggested a moderate-to-large effect size in reducing anxiety, depression, stress, and systolic blood pressure. Conclusions: Although a high heterogeneity was observed in the methodological approaches, scientific literature confirmed that MBI can now be translated into a first-line intervention tool for improving physical and psychological wellbeing in CVD patients.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227381/

 

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*
Website